JP2017521490A5 - - Google Patents

Download PDF

Info

Publication number
JP2017521490A5
JP2017521490A5 JP2017519730A JP2017519730A JP2017521490A5 JP 2017521490 A5 JP2017521490 A5 JP 2017521490A5 JP 2017519730 A JP2017519730 A JP 2017519730A JP 2017519730 A JP2017519730 A JP 2017519730A JP 2017521490 A5 JP2017521490 A5 JP 2017521490A5
Authority
JP
Japan
Prior art keywords
htra
amino acids
bacterial
fragment
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017519730A
Other languages
English (en)
Japanese (ja)
Other versions
JP6634444B2 (ja
JP2017521490A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2015/000380 external-priority patent/WO2016000022A1/en
Publication of JP2017521490A publication Critical patent/JP2017521490A/ja
Publication of JP2017521490A5 publication Critical patent/JP2017521490A5/ja
Application granted granted Critical
Publication of JP6634444B2 publication Critical patent/JP6634444B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017519730A 2014-06-30 2015-06-30 ヘリコバクター治療 Active JP6634444B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2014902493 2014-06-30
AU2014902493A AU2014902493A0 (en) 2014-06-30 Helicobacter therapeutic
PCT/AU2015/000380 WO2016000022A1 (en) 2014-06-30 2015-06-30 Helicobacter therapeutic

Publications (3)

Publication Number Publication Date
JP2017521490A JP2017521490A (ja) 2017-08-03
JP2017521490A5 true JP2017521490A5 (enExample) 2018-08-09
JP6634444B2 JP6634444B2 (ja) 2020-01-22

Family

ID=55018143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017519730A Active JP6634444B2 (ja) 2014-06-30 2015-06-30 ヘリコバクター治療

Country Status (9)

Country Link
US (3) US20170165347A1 (enExample)
EP (1) EP3160492A4 (enExample)
JP (1) JP6634444B2 (enExample)
KR (1) KR102481455B1 (enExample)
CN (2) CN113694191A (enExample)
AU (1) AU2015283805B2 (enExample)
BR (1) BR112016030728A2 (enExample)
RU (1) RU2017100658A (enExample)
WO (1) WO2016000022A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101885460B1 (ko) 2017-02-07 2018-08-03 두산중공업 주식회사 가스터빈용 프리 스월러 장치
CN108531468B (zh) * 2018-02-24 2020-07-17 广东工业大学 编码重组幽门螺杆菌丝氨酸蛋白酶的基因、卵黄抗体与应用
KR102500799B1 (ko) 2018-03-09 2023-02-20 삼성디스플레이 주식회사 트랜지스터 기판 및 이를 구비하는 표시 장치
RU2746590C1 (ru) * 2020-10-12 2021-04-16 Федеральное государственное бюджетное образовательное учреждение высшего образования "Вятский государственный университет" Способ эрадикации бактерий Helicobacter pylori при экспериментальном хеликобактериозе у конвенциональных белых мышей и средство для его осуществления

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US5643578A (en) 1992-03-23 1997-07-01 University Of Massachusetts Medical Center Immunization by inoculation of DNA transcription unit
DE69536091D1 (de) 1994-01-27 2010-09-09 Univ Massachusetts Medical Immunisierung durch Impfung von DNS Transkriptionseinheit
US5939400A (en) 1996-02-26 1999-08-17 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for induction of suppressive T cell response
AU3210997A (en) 1996-05-24 1997-12-09 University Of Maryland At Baltimore Dna vaccines for eliciting a mucosal immune response
CA2288211A1 (en) * 1997-04-25 1998-11-05 Genelabs Technologies, Inc. Antigenic composition and method of detection for helicobacter pylori
IT1298087B1 (it) 1998-01-08 1999-12-20 Fiderm S R L Dispositivo per il controllo della profondita' di penetrazione di un ago, in particolare applicabile ad una siringa per iniezioni
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
US6585975B1 (en) * 1998-04-30 2003-07-01 Acambis, Inc. Use of Salmonella vectors for vaccination against helicobacter infection
AUPP684998A0 (en) * 1998-10-30 1998-11-26 Murdoch Institute for Research into Birth Defects Limited, The A method of recombination and agents useful for same
US6319224B1 (en) 1999-08-20 2001-11-20 Bioject Medical Technologies Inc. Intradermal injection system for injecting DNA-based injectables into humans
US6494865B1 (en) 1999-10-14 2002-12-17 Becton Dickinson And Company Intradermal delivery device including a needle assembly
DE60124526D1 (de) * 2000-04-27 2006-12-28 Max Planck Gesellschaft Methode zur identifizierung von helicobacter antigenen
US7015033B1 (en) * 2000-05-25 2006-03-21 Aventis Pasteur Limited Co-expression of recombination proteins
GB0103170D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
FR2815544B1 (fr) 2000-10-23 2003-02-14 Poudres & Explosifs Ste Nale Seringue sans aiguille securisee a architecture compacte
AT410798B (de) * 2001-01-26 2003-07-25 Cistem Biotechnologies Gmbh Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen
JP2007524366A (ja) * 2003-04-22 2007-08-30 インターツェル・アクチェンゲゼルシャフト ピロリ菌抗原
US7868139B2 (en) * 2006-01-24 2011-01-11 Uab Research Foundation Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
EP2004678A1 (en) * 2006-03-15 2008-12-24 Csir Modulation of glutamine synthetase activity
US20110250221A1 (en) * 2007-08-24 2011-10-13 University Of Wollongong Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
WO2010068413A1 (en) * 2008-11-25 2010-06-17 Emergent Product Development Gaithersburg Inc. Chlamydia vaccine comprising htra polypeptides

Similar Documents

Publication Publication Date Title
JP2013534532A5 (enExample)
JP2007097598A5 (enExample)
JP2016528247A5 (enExample)
JP2018527919A5 (enExample)
JP2012522808A5 (enExample)
JP2011250797A5 (enExample)
JP2016529229A5 (enExample)
SI2691112T1 (en) STABILITY FORMULATION PROTITELES FOR HUMAN PROGRAMMED DEPRESSOR RECEPTOR PD-1 AND RELATED HEALTH
PE20181336A1 (es) Anticuerpos que se unen a interleucina 8 (il-8) y sus usos
NO20076239L (no) Peptidkonjugatpreparater og fremgangsmater for forebygging og behandling av Alzheimers sykdom
JP2012504955A5 (enExample)
JP2012525128A5 (enExample)
MY205774A (en) Human il-4r binding antibody, antigen binding fragment thereof, and medical use thereof
JP2016539946A5 (enExample)
JP2015522252A5 (enExample)
JP2017521490A5 (enExample)
JP2016503413A5 (enExample)
JP2017532313A5 (enExample)
JP2018505882A5 (enExample)
JP2019509054A5 (enExample)
JP2017515473A5 (enExample)
Zhang et al. Longevity of Sm-p80-specific antibody responses following vaccination with Sm-p80 vaccine in mice and baboons and transplacental transfer of Sm-p80-specific antibodies in a baboon
JP2018529661A5 (enExample)
JP2017505305A5 (enExample)
JP2015529677A5 (enExample)